Clinical use of granulocyte colony-stimulating factor in infectious diseases.
Gaviria
J M
JM
University of Washington Seattle, Washington Physician, Infectious Diseases, Mid-Columbia Medical Associates, Kennewick, Washington, USA.
Garrido
S M
SM
Root
R K
RK
D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D002633:Chemotaxis / Q000187:drug effects; D003141:Communicable Diseases / Q000188:drug therapy*; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects / Q000502:physiology / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D008297:Male; D009503:Neutropenia / Q000188:drug therapy / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic
D016179:Granulocyte Colony-Stimulating Factor